LBX Pharmacy Chain Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Li Wang

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	no data
CEO sahipliği	0.01%
Yönetim ortalama görev süresi	2.2yrs
Yönetim Kurulu ortalama görev süresi	3.2yrs

Son yönetim güncellemeleri

Recent updates

CEO

Li Wang (42 yo)

no data

Görev süresi

CN¥2,230,000

Tazminat

Ms. Li Wang is President of LBX Pharmacy Chain Joint Stock Company. She was General Manager of the Strategic Investment Center & Executive Director of LBX Pharmacy Chain Joint Stock Company. She has Master...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Xin Wan	Vice President	2.2yrs	CN¥1.31m	0.0052% CN¥ 698.4k
Shiyong Su	Vice President	3.4yrs	CN¥1.16m	0.0052% CN¥ 698.4k
Yufei Jiang	Vice President	3.3yrs	CN¥1.28m	0.0052% CN¥ 698.4k
Li Wang	President	no data	CN¥2.23m	0.013% CN¥ 1.7m
Lishan Chen	CFO & Head of Finance	less than a year	Veri yok	Veri yok
Shi Lei	Head of Accounting	no data	Veri yok	Veri yok
Shini Feng	Board Secretary	no data	CN¥820.00k	0.0098% CN¥ 1.3m
Wenshuai Zhang	Vice President	less than a year	Veri yok	Veri yok

2.2yrs

Ortalama Görev Süresi

42yo

Ortalama Yaş

Deneyimli Yönetim: 603883 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.2 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Mingchuan Ren	Independent Director	less than a year	Veri yok	Veri yok
Lianfeng Wu	Independent Director	3.8yrs	CN¥100.00k	Veri yok
Zilong Xie	Chairman	10.6yrs	CN¥2.16m	27.9% CN¥ 3.7b
Jiaqi Zheng	Director	no data	Veri yok	Veri yok
Bin Wu	Director	no data	CN¥100.00k	Veri yok
Zhen Li	Director	2.5yrs	Veri yok	Veri yok
Bin Wu	Director	no data	Veri yok	0.00025% CN¥ 33.5k
Qun Luo	Employee Supervisor	3.8yrs	Veri yok	Veri yok
Chee Kay Tse	Independent Director	2.7yrs	CN¥100.00k	Veri yok

3.2yrs

Ortalama Görev Süresi

56yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 603883 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.2 yıldır).

LBX Pharmacy Chain Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

LBX Pharmacy Chain Joint Stock Company, Annual General Meeting, Jun 13, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Investor sentiment improves as stock rises 18%

Third quarter 2024 earnings released: EPS: CN¥0.17 (vs CN¥0.26 in 3Q 2023)

Upcoming dividend of CN¥0.33 per share

LBX Pharmacy Chain Joint Stock Company to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 15%

Investor sentiment improves as stock rises 23%

Now 24% undervalued after recent price drop

LBX Pharmacy Chain Joint Stock Company to Report First Half, 2024 Results on Aug 30, 2024

Investor sentiment deteriorates as stock falls 17%

Dividend increased to CN¥0.66

LBX Pharmacy Chain Joint Stock Company, Annual General Meeting, Jun 13, 2024

Full year 2023 earnings released: EPS: CN¥1.59 (vs CN¥1.36 in FY 2022)

LBX Pharmacy Chain Joint Stock Company to Report Q1, 2024 Results on Apr 30, 2024

Investor sentiment improves as stock rises 18%

LBX Pharmacy Chain Joint Stock Company to Report Fiscal Year 2023 Results on Apr 30, 2024

Third quarter 2023 earnings released: EPS: CN¥0.34 (vs CN¥0.26 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.38 (vs CN¥0.38 in 2Q 2022)

Full year 2022 earnings released: EPS: CN¥1.36 (vs CN¥1.26 in FY 2021)

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

Now 22% undervalued

Investor sentiment improved over the past week

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.26 (vs CN¥0.24 in 3Q 2021)

First quarter 2022 earnings released: EPS: CN¥0.53 (vs CN¥0.56 in 1Q 2021)

Less than half of directors are independent

LBX Pharmacy Chain Joint Stock Company (SHSE:603883) agreed to acquire 51% stake in Hebei Hua Tuo Pharmacy Medicine Chain Co., Ltd. from Zhang Weijun, Tian Jinping, Ma Zhirong and Guo Zhihong fro CNY 1.4 billion.

Second quarter 2021 earnings released: EPS CN¥0.43 (vs CN¥0.35 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.56 (vs CN¥0.49 in 1Q 2020)

New 90-day low: CN¥61.56

New 90-day high: CN¥81.64

Investor sentiment improved over the past week

New 90-day low: CN¥63.60

New 90-day low: CN¥65.89

New 90-day low: CN¥67.21

Laobaixing Reportedly in Merger Talks with Yixintang

Third quarter earnings released

Laobaixing Pharmacy Chain Joint Stock Company to Report Q3, 2020 Results on Oct 30, 2020

New 90-day high - CN¥90.80

First half earnings released

Laobaixing Pharmacy Chain Joint Stock Company to Report First Half, 2020 Results on Aug 21, 2020

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş